| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.79▲ | 4.80▲ | 4.80▲ | 4.80▲ | 4.98▲ |
| MA10 | 4.66▲ | 4.59▲ | 4.59▲ | 4.49▲ | 6.21▼ |
| MA20 | 4.40▲ | 4.30▲ | 4.30▲ | 4.82▲ | 6.03▼ |
| MA50 | 4.24▲ | 4.42▲ | 4.66▲ | 6.23▼ | 3.79▲ |
| MA100 | 4.72▲ | 5.60▼ | 6.33▼ | 5.70▼ | 12.28▼ |
| MA200 | 6.25▼ | 6.25▼ | 6.00▼ | 3.64▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.071▲ | 0.120▲ | 0.142▲ | 0.132▲ | -0.259▼ |
| RSI | 69.568▲ | 64.571▲ | 62.265▲ | 48.733▼ | 48.985▼ |
| STOCH | 86.335▲ | 92.256▲ | 92.256▲ | 73.710 | 12.122▼ |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -30.093 | -81.807▼ |
| CCI | 190.253▲ | 160.199▲ | 160.199▲ | 75.018 | -83.987 |
| MA | $BDRX Price Crossed Above MA(26) | Set Alert |
|
Wednesday, December 03, 2025 11:48 AM
NYSE:BDX Earnings and Revenue History December 3rd 2025 How Do Unusual Items Influence Profit? Importantly, our data indicates that Becton Dickinson's profit was reduced by US$1.3 ...
|
|
Monday, December 01, 2025 05:41 AM
December 1, 2025Biodexa Announces Enrolment of First European Patients into Pivotal Phase 3 Serenta Trial in FAPBiodexa Pharmaceuticals PLC ...
|
|
Friday, November 28, 2025 03:34 AM
Key Insights The projected fair value for Becton Dickinson is US$322 based on 2 Stage Free Cash Flow to Equity ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 04/12/25 | 4.86 | 5.124 | 4.705 | 5.09 | 18,100 |
| 03/12/25 | 4.78 | 5.16 | 4.49 | 4.91 | 51,500 |
| 02/12/25 | 4.70 | 4.88 | 4.44 | 4.86 | 24,300 |
| 01/12/25 | 4.57 | 4.70 | 4.395 | 4.63 | 20,500 |
| 28/11/25 | 4.43 | 4.55 | 4.33 | 4.53 | 12,553 |
| 26/11/25 | 3.91 | 4.38 | 3.91 | 4.35 | 36,100 |
| 25/11/25 | 4.20 | 4.20 | 3.60 | 3.907 | 88,900 |
| 24/11/25 | 4.23 | 4.80 | 3.94 | 4.32 | 157,300 |
| 21/11/25 | 3.93 | 4.38 | 3.92 | 4.38 | 8,500 |
| 20/11/25 | 4.01 | 4.44 | 3.93 | 3.93 | 41,300 |
|
|
||||
|
|
||||
|
|